DEPOMED INC (DEPO)

Overview Price 6.53 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $6.53 Daily Range $0.00 - $0.00 52-Week Range $4.20 - $10.19 Volume 0 Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects, improving patient convenience, compliance and pharmacokinetic profiles. ProQuin XR extended-release tablets have been approved by the FDA for the once-daily treatment of uncomplicated urinary tract infections and are currently being marketed in the United States. In addition, once-daily Glumetza has been approved for use in adults with type two diabetes and is currently being marketed in the United States and Canada. The company is currently evaluating Gabapentin GR for the treatment of two pain indications, postherpetic neuralgia and diabetic peripheral neuropathy, and menopausal hot flashes. Other Resources for DEPO Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Company News for February 7, 2012 February 7, 2012 Zacks Blog: Gralise IP Solid January 24, 2012 Zacks Blog: Upgrading Depomed To Outperform August 9, 2011 Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects, improving patient convenience, compliance and pharmacokinetic profiles. ProQuin XR extended-release tablets have been approved by the FDA for the once-daily treatment of uncomplicated urinary tract infections and are currently being marketed in the United States. In addition, once-daily Glumetza has been approved for use in adults with type two diabetes and is currently being marketed in the United States and Canada. The company is currently evaluating Gabapentin GR for the treatment of two pain indications, postherpetic neuralgia and diabetic peripheral neuropathy, and menopausal hot flashes.   Brokerage Analyst Recommendations 5 Brokerage Firms Covering DEPO   Strong Buy 5 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   DEPO Ratings: BUY  SELL  HOLD DEPO Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 19 Buy 0 Sell   Top Buy Analysis BUY: DEPO Company: DEPOMED INC. Points: 4.38 Start Price: $6.16 Start Date: 01/21/2012 2:53 PM Gordon_Gekko P&P Score: 98.44 Recs: Low PEG. Recent analyst upgrades. Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
zantriocom	0.00	06/08/10	Zantrio.com Free Daily Stock Picks 6-8-2010	0
Zacks_Analysts	0.00	01/24/12	Gralise IP Solid - Analyst Blog	0
Zacks_Analysts	0.00	01/06/11	Glumetza 500 mg Supply Resumed - Analyst Blog	0
Zacks_Analysts	0.00	11/16/10	Santarus Hit by Generic Zegerid - Analyst Blog	0
Zacks_Analysts	0.00	10/05/10	Neutral on Santarus - Analyst Blog	0
Zacks_Analysts	0.00	08/06/10	Depomed Fundamentals Look Strong - Analyst Blog	0
Zacks_Analysts	0.00	08/04/10	Santarus Beats on Higher Revs - Analyst Blog	0
Zacks_Analysts	0.00	05/14/10	Zacks Analyst Blog Highlights: Sony Corp., Kohl's Corp., Santarus, Inc., Merck and Depomed - Press Releases	0
Zacks_Analysts	0.00	05/13/10	Santarus Beats Expectations - Analyst Blog	0
Zacks_Analysts	0.00	04/19/10	Zacks Analyst Blog Highlights: General Electric Company, First Horizon National Corporation, Genuine Parts Company, Santarus and Depomed - Press Releases	0

Pages: [ 1 ]  2   3  >>

Commentary

BUY: DEPOMED INC. (DEPO) Start Price: $6.16 Points: +4.38 Created: 01/21/2012 Low PEG. Recent analyst upgrades. Comments: 0 | Comment Gordon_Gekko Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $3.97 Points: +40.65 Created: 10/11/2009 Breaking out on good volume after positive trial results. Great rev growth. Hopefully this momentum will continue. Comments: 0 | Comment OnIslandTrader Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $2.00 Points: +177.84 Created: 05/21/2009 FDA Phase III for FIRST non harmonal drup to be completed by OCT and will most likely be successful Comments: 0 | Comment aabrentmary Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $4.57 Points: +35.26 Created: 10/21/2011 Comments: 0 | Comment sunlk2 Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $8.18 Points: -21.67 Created: 06/30/2011 Comments: 0 | Comment dmonnie Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $4.24 Points: +49.87 Created: 08/21/2008 Comments: 0 | Comment deviljix Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $6.40 Points: +11.05 Created: 01/01/2008 Comments: 0 | Comment hydro_jazzy Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $6.69 Points: +6.58 Created: 01/01/2008 Comments: 0 | Comment TexasTeeee Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $6.77 Points: +5.41 Created: 01/01/2008 Comments: 0 | Comment 1skystar Recs:

BUY: DEPOMED INC. (DEPO) Start Price: $6.56 Points: +8.53 Created: 01/01/2008 Comments: 0 | Comment paul673 Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Gordon_Gekko	98.44	BUY	One to Three Months	01/21/2012	$6.16	$6.60 (-4.76%)	+7.14%	+2.76%	+4.38	view close
sunlk2	99.79	BUY	Three to Six Months	10/21/2011	$4.57	$6.60 (-4.76%)	+44.42%	+9.16%	+35.26
dmonnie	0.21	BUY	One to Three Months	06/30/2011	$8.18	$6.60 (-4.76%)	-19.32%	+2.35%	-21.67
OnIslandTrader	0.28	BUY	Six Months to a Year	10/11/2009	$3.97	$6.60 (-4.76%)	+66.25%	+25.60%	+40.65	view close
aabrentmary		BUY	One to Three Months	05/21/2009	$2.00	$6.60 (-4.76%)	+230.00%	+52.16%	+177.84	view close
deviljix	60.96	BUY	Six Months to a Year	08/21/2008	$4.24	$6.60 (-4.76%)	+55.66%	+5.79%	+49.87
hydro_jazzy	42.27	BUY	Six Months to a Year	01/01/2008	$6.40	$6.60 (-4.76%)	+3.12%	-7.92%	+11.05
TexasTeeee	59.97	BUY	Six Months to a Year	01/01/2008	$6.69	$6.60 (-4.76%)	-1.35%	-7.92%	+6.58
1skystar		BUY	Six Months to a Year	01/01/2008	$6.77	$6.60 (-4.76%)	-2.51%	-7.92%	+5.41
paul673		BUY	Six Months to a Year	01/01/2008	$6.56	$6.60 (-4.76%)	+0.61%	-7.92%	+8.53

Pages: [ 1 ]  2  >>